Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,135 | Dovepress* | 6,650+ | 460 | 7,110 | |
PubMed Central* | 485 | 106 | 591 | ||
Totals | 7,135 | 566 | 7,701 | ||
*Since 2 May 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar